ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1010

Advanced Clinician Practitioners in Arthritis Care: A Workforce Profile

Laura Passalent1, Soever Leslie1, Amanda Steiman2, Christopher Nielsen1, Deborah Levy3 and Robert Inman4, 1Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada, 2Sinai Health System, Toronto, ON, Canada, 3The Hospital for Sick Children, Toronto, ON, Canada, 4University Health Network, Toronto, ON, Canada

Meeting: ACR Convergence 2023

Keywords: Access to care, Health Services Research, Surveys, Work Force

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (0993–1012) Health Services Research Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The Advanced Clinician Practitioner in Arthritis Care (ACPAC) Program is a post-licensure, competency-based academic and clinical educational program that prepares physiotherapists, occupational therapists, nurses, and chiropractors for extended practice roles in the diagnosis and management of patients with arthritis, autoimmune and other musculoskeletal (MSK) conditions. Since 2005, the program has graduated extended role providers (ERPs) to manage a growing population of patients with MSK conditions; address a progressive decline in MSK specialists and better utilize health professionals to improve access to care. The objective of this study was to profile the current ACPAC workforce with respect to 1) demographics, including aspects of ethnicity, diversity and inclusion; 2) practice setting and clinical roles; 3) health system integration and 4) remuneration.

Methods: ACPAC graduates from 2006 to 2022 were sent an electronic questionnaire from February to April 2023 using Research Electronic Data CAPture software. The questionnaire was developed based on review of workforce literature and was reviewed by the investigative team for face and content validity, clarity, relevance and format. Univariate statistics were used to summarize data. All analyses were conducted in SAS v9.4.

Results: Seventy-two of 103 graduates completed the questionnaire (response rate 69.9%). Demographics: Most respondents were from Ontario, Canada (95.8%) and were physiotherapists (78.8%). Mean age was 49.4 (SD 9.2) years. The majority identified as women (77.8%) and White-North American/European ethnicity (71.8%). No respondents identified as North American Indigenous. Practice setting and clinical roles:Most reported current employment in an ERP role (76.4%). There were inconsistencies regarding ERP title. The majority (80%) were working in hospital-based settings (80%). Across all settings, 89.1% worked with adult populations, and provided either orthopaedic (54.5%) or rheumatology (40%) care. Only 12.2% reported working in rural or remote settings. Health system integration: Respondents reported working in various orthopaedic and rheumatology models of care including triage, interprofessional collaborative care programs and transition clinics from paediatric to adult care. Remuneration: Most funding models were from government sources (90.9%) with almost half (47.2%) reporting an annual salary of at least $100,000 CAD.

Conclusion: Most ACPAC ERPs are physiotherapists working in urban publicly-funded, hospital-based practices providing adult orthopaedic and rheumatology care. Opportunity exists to maximize employment of existing graduates and further expand ERP roles beyond hospital-based settings, and in rural and remote areas. Examples include family medicine clinics, community-based clinics, geriatric care, and emergency departments. A small proportion of respondents identified as non-white, with Indigenous individuals not represented in this workforce. There is value in targeting recruitment strategies to attract program candidates representative of diverse ethnic backgrounds and inclusive of Indigenous populations.


Disclosures: L. Passalent: AbbVie/Abbott, 6, Novartis, 6, UCB, 2, 5; S. Leslie: None; A. Steiman: AstraZeneca, 6, GlaxoSmithKlein(GSK), 6, Pfizer, 5; C. Nielsen: None; D. Levy: None; R. Inman: AbbVie, 2, Eli Lilly, 2, Janssen, 2, Novartis, 2, Sandoz, 2.

To cite this abstract in AMA style:

Passalent L, Leslie S, Steiman A, Nielsen C, Levy D, Inman R. Advanced Clinician Practitioners in Arthritis Care: A Workforce Profile [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/advanced-clinician-practitioners-in-arthritis-care-a-workforce-profile/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/advanced-clinician-practitioners-in-arthritis-care-a-workforce-profile/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology